JTM's Tumor immunology goes broad: announcing the Immunobiology and Immunotherapy section.

Détails

Ressource 1Télécharger: BIB_24E72A1EEBF5.P001.pdf (121.12 [Ko])
Etat: Public
Version: de l'auteur
ID Serval
serval:BIB_24E72A1EEBF5
Type
Article: article d'un périodique ou d'un magazine.
Sous-type
Editorial
Collection
Publications
Institution
Titre
JTM's Tumor immunology goes broad: announcing the Immunobiology and Immunotherapy section.
Périodique
Journal of Translational Medicine
Auteur(s)
Bot A., Marincola F., Romero P.
ISSN
1479-5876 (Electronic)
ISSN-L
1479-5876
Statut éditorial
Publié
Date de publication
2013
Volume
11
Numéro
1
Pages
2
Langue
anglais
Résumé
For the last four years the Journal of Translational Medicine (JTM) has hosted the Section of Tumor Immunology and Biological Cancer Therapy. Under the editorial leadership of Dr. Pedro Romero and with the direct support of the Society for Immunotherapy of Cancer (SITC), this section enriched the communication between basic immunological sciences and the clinical investigation arena in oncology. We are re-launching this Section of JTM, now entitled Immunobiology and Immunotherapy, succeeding Tumor Immunology and Biological Cancer Therapy. While aiming to build on the editorial success and focus of its predecessor, this novel Section will have a broader scope, hosting translational immunology topics pertaining to immunotherapy beyond oncology, including disciplines such as inflammation, autoimmunity, transplantation, metabolic disorders and others. As the vision of this re-launched Section of JTM broadens up to serve a communication need for translational immunologists involved with immunotherapy irrespectively of the therapeutic area, a novel and focused journal entitled Journal for Immunotherapy of Cancer (JITC) has just been initiated, sponsored by the SITC.
Pubmed
Web of science
Open Access
Oui
Création de la notice
23/01/2013 14:00
Dernière modification de la notice
20/08/2019 13:03
Données d'usage